Learn more

XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTD

Overview
  • Total Patents
    17
  • GoodIP Patent Rank
    204,740
  • Filing trend
    ⇩ 100.0%
About

XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTD has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are G1 THERAPEUTICS INC, SIGA TECHNOLOGIES INC and BAGO SA LABOR.

Patent filings in countries

World map showing XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTDs patent filings in countries

Patent filings per year

Chart showing XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ma Qin 15
#2 Fan Wenxi 15
#3 Wu Jialin 14
#4 Wang Zihou 13
#5 Guo Liang 10
#6 Zhou Fan 9
#7 Sun Jie 8
#8 Shang Jing 6
#9 Cao Rihui 5
#10 Shi Buxi 4

Latest patents

Publication Filing date Title
CN110251607A A kind of Traditional Chinese medicine for relieving vision fatigue compound preparation and preparation method thereof
CN106963833A A kind of medicine for treating children and adults' flu and preparation method thereof
CN106349257A 3-bit piperazine bridge connected di-beta-carboline alkali type compound and pharmaceutical application thereof
CN104490979A Application of rhodiola rosea extract in preparation of medicine resistant to adverse effects during radiotherapy and chemotherapy
CN104744494A 7 site-connected bis(beta-carboline alkaloid) compound and its preparation method, pharmaceutical composition and use
CN104177377A 3-Position diamine beta-carboline alkali compound, and preparation method, medicinal composition and use thereof
CN104177376A 1-Position diamine beta-carboline alkali compound, and preparation method, medicinal composition and use thereof
CN104755078A Application of harmine derivatives in preparation of antimicrobial agents
WO2014079070A1 Bis-β-carboline compound and preparation method, pharmaceutical composition and use thereof
CN103070862A Application of Harmine derivative to preparation of antibacterial medicine
CN102952151A 3-position bis-beta-carboline alkali compound, and preparation method, pharmaceutical composition and application thereof
CN102796124A Di-beta-carboline alkali compound and preparation method, medicinal composition and application thereof